India: Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

The Proposed Medical Devices (Amendment) Rules, 2026: A Comprehensive Analysis Of Regulatory Modifications To The Medical Devices Framework

The Central Government, exercising its rule-making authority under Section 12(1) and Section 33(1) of the Drugs and Cosmetics Act, 1940, has proposed significant amendments to the Medical Devices Rules, 2017...

India Healthcare

IL

IndiaLaw LLP

Life Sciences And Healthcare Newsletter | March 2026

The life sciences and healthcare industry in India continues to evolve through regulatory and policy developments. In March 2026, key developments included proposed frameworks for post-approval...

India Healthcare

DL

Dentons Link Legal

Trump’s 100% Pharma Tariffs: What India’s Pharmaceutical Exporters Must Know

On 2 April 2026, the United States issued a Presidential Proclamation titled “Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients into the United States,”...

India Healthcare

IL

IndiaLaw LLP

From Periodic To Perpetual: Legal Implications Of India's New Food Safety Licensing Regime

The Food Safety and Standards Authority of India (FSSAI) has introduced significant amendments to the Food Safety and Standards (Licensing and Registration of Food Businesses) Regulations through its 2026 Amendment...

India Healthcare

IL

IndiaLaw LLP

Regulating The Price Of Health: A Legal Analysis Of India’s 2026 Drug Ceiling Price Notification

India Healthcare

IL

IndiaLaw LLP

Public Health At A Crossroads: Legal And Regulatory Dimensions Of The Proposed Drugs Rules Amendment, 2026

India Healthcare

IL

IndiaLaw LLP

Easing Compliance Burden: Analysis Of Revised FSSAI Licensing Thresholds

India Healthcare

IL

IndiaLaw LLP

Transforming Food Business Regulation: An Analysis Of The 2026 Amendments To FSS (Licensing And Registration) Regulations

India Healthcare

IL

IndiaLaw LLP

Life Sciences And Healthcare Newsletter | February 2026

India Healthcare

DL

Dentons Link Legal

Life Sciences And Healthcare Newsletter | January 2026

India Healthcare

DL

Dentons Link Legal

Ensuring Integrity In Food Testing: FSSAI's Enforcement Of Statutory Obligations Through InFoLNet Integration And NABL Accreditation Compliance

India Healthcare

IL

IndiaLaw LLP

Defining Safety In Food Contact Materials: Analysis Of The Draft Food Safety And Standards (Packaging) Amendment Regulations, 2026

India Healthcare

IL

IndiaLaw LLP

Reassessing India's Medical Device Recall Framework: Regulatory Gaps And The Case For Reform

India Healthcare

La

Luthra and Luthra Law Offices India

Union Budget 2026‑2027: Catalysing The Next Wave Of Growth For India's Care Economy

India Healthcare

AP

AK & Partners

RERA Cracks Down On Pre-Launch Ads | ₹1 Lakh Penalty On Alphabet Infra | RERA Bihar Order Explained (Video)

India Real Estate

IL

IndiaLaw LLP

RBI's Revised Dividend Framework (2026): Implications For Bank Valuations And Investor Returns (Video)

IL

IndiaLaw LLP

Non-Compete Restrictions Under Indian Law: From The Lens Of The Mufg-Shriram Finance Deal

KC

Khaitan & Co LLP

RBI’s 2026 Digital Banking And Governance Overhaul: Key Action Points For Banks And NBFCs

LP

Legitpro Law

Gambling Laws And Regulations India 2026

India Media & IT

AL

Aarna Law

See more

Food and Drugs Law

The Rise Of Sound-Alike Pharmaceutical Trademarks: A Public Health Crisis?

A physician prescribes Olvance, an antihypertensive with Olmesartan, whiles the pharmacist, distracted and in a hurry, pulls Oleanz, an antipsychotic with Olanzapine. The two names share similar opening and internal letter patterns.

Ka

Khurana and Khurana

Life Sciences And Healthcare Newsletter | March 2026

The life sciences and healthcare industry in India continues to evolve through regulatory and policy developments. In March 2026, key developments included proposed frameworks for post-approval...

India Healthcare

DL

Dentons Link Legal

Regulatory Compliance Newsletter | February 2026

This newsletter covers categories of updates relating to labour, environment, corporate, financial, industry related and miscellaneous laws. Notification of Gujarat Shops and Establishments...

India Compliance

DL

Dentons Link Legal

The Proposed Medical Devices (Amendment) Rules, 2026: A Comprehensive Analysis Of Regulatory Modifications To The Medical Devices Framework

India Healthcare

IL

IndiaLaw LLP

Trump’s 100% Pharma Tariffs: What India’s Pharmaceutical Exporters Must Know

India Healthcare

IL

IndiaLaw LLP

From Periodic To Perpetual: Legal Implications Of India's New Food Safety Licensing Regime

India Healthcare

IL

IndiaLaw LLP

When Public Interest Tempers Interim Patent Relief: The Nivolumab Biosimilar Ruling

RS

Remfry & Sagar

The Masala Dosa Economy: The Law Behind India’s Supply Chains

India Commercial

KS

King, Stubb & Kasiva

Regulating The Price Of Health: A Legal Analysis Of India’s 2026 Drug Ceiling Price Notification

India Healthcare

IL

IndiaLaw LLP

See more

Life Sciences, Biotechnology & Nanotechnology

Life Sciences And Healthcare Newsletter | March 2026

The life sciences and healthcare industry in India continues to evolve through regulatory and policy developments. In March 2026, key developments included proposed frameworks for post-approval...

India Healthcare

DL

Dentons Link Legal

Regulating The Price Of Health: A Legal Analysis Of India’s 2026 Drug Ceiling Price Notification

On March 25, 2026, the National Pharmaceutical Pricing Authority (NPPA), operating under the aegis of the Ministry of Chemicals and Fertilizers (Department of Pharmaceuticals), Government of India...

India Healthcare

IL

IndiaLaw LLP

Public Health At A Crossroads: Legal And Regulatory Dimensions Of The Proposed Drugs Rules Amendment, 2026

On 9th March 2026, the Ministry of Health and Family Welfare, Government of India, published a significant draft amendment to the Drugs Rules, 1945, by way of Gazette Notification G.S.R. 164(E).

India Healthcare

IL

IndiaLaw LLP

Life Sciences And Healthcare Newsletter | February 2026

India Healthcare

DL

Dentons Link Legal

Project BUILD – Takeaways From Our Bilateral, Multistakeholder, And Interdisciplinary Exploration On Building Inclusive AI In Healthcare

India Technology

I

Ikigai Law

Life Sciences And Healthcare Newsletter | January 2026

India Healthcare

DL

Dentons Link Legal

Reassessing India's Medical Device Recall Framework: Regulatory Gaps And The Case For Reform

India Healthcare

La

Luthra and Luthra Law Offices India

Karnataka's Proposed Good Samaritan And Medical Professional Protection Rules, 2026: A Comprehensive Legal Framework For Emergency Medical Assistance

India Healthcare

IL

IndiaLaw LLP

Checking The Pulse - Recent Legal Developments In The Indian Healthcare And Pharma Sector

India Healthcare

I

CMS INDUSLAW

See more

Healthcare

Post-Acquisition Indemnity Failures: What VPS Healthcare’s Rs15.86 Crore Legal Battle Teaches Dealmakers

VPS Healthcare’s acquisition of Rockland Hospitals offers a cautionary tale in M&A structuring. A seven-year enforcement battle over a disclosed ₹10 crore EY arbitration claim exposed deep structural weaknesses...

India Commercial

IL

IndiaLaw LLP

IRDAI's Regulatory Sandbox Regulations 2025: Key Changes For Insurance Innovation

The IRDAI first introduced the regulatory sandbox framework in 2019 with the objective of permitting controlled experimentation in the insurance sector while maintaining policyholder protection and orderly market development.

India Insurance

TC

Tuli & Co

The Rise Of Sound-Alike Pharmaceutical Trademarks: A Public Health Crisis?

A physician prescribes Olvance, an antihypertensive with Olmesartan, whiles the pharmacist, distracted and in a hurry, pulls Oleanz, an antipsychotic with Olanzapine. The two names share similar opening and internal letter patterns.

Ka

Khurana and Khurana

Life Sciences And Healthcare Newsletter | March 2026

India Healthcare

DL

Dentons Link Legal

The Proposed Medical Devices (Amendment) Rules, 2026: A Comprehensive Analysis Of Regulatory Modifications To The Medical Devices Framework

India Healthcare

IL

IndiaLaw LLP

Trump’s 100% Pharma Tariffs: What India’s Pharmaceutical Exporters Must Know

India Healthcare

IL

IndiaLaw LLP

Regulating The Price Of Health: A Legal Analysis Of India’s 2026 Drug Ceiling Price Notification

India Healthcare

IL

IndiaLaw LLP

Public Health At A Crossroads: Legal And Regulatory Dimensions Of The Proposed Drugs Rules Amendment, 2026

India Healthcare

IL

IndiaLaw LLP

Life Sciences And Healthcare Newsletter | February 2026

India Healthcare

DL

Dentons Link Legal

See more

Latest Videos

See more

FSSAI's New Rule: Quarterly Reports On Expired & Rejected Food! (Video)

IL

IndiaLaw LLP

A Landmark Judgment On Altruistic Organ Donation (Video)

IL

IndiaLaw LLP

Sidharrth Shankar | Indian Healthcare Sector In 2023 And Way Forward In 2024 (Video)

J

JSA

India's Attractiveness And Opportunities In Healthcare (Video)

NP

Nexdigm Private Limited

TiE Event – My Story With Ajit Nagral (July 06, 2018) (Video)

ND

Nishith Desai Associates

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More